The legacy of the blue pill offers a complex case study for analysts eyeing drug companies. While first sales were astounding, present patent lapse and the emergence of cheaper versions have severely influenced https://phoenixprzb686156.blogofoto.com/72456246/the-blue-pill-and-the-pharmaceutical-industry-a-precarious-bet